At odds with most previous findings, Jayaraman et al. have also uncovered that although cancer-induced MDSCs play a key role in tumour immune evasion, they can be conditioned with TGF-β1 to acquire a novel immune-stimulatory phenotype, losing the ability to inhibit T cell proliferation and acquiring an enhanced antigen-presenting capability. Here, TGFB1 is linked to cancer.